Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Triple-Drug attack on cervical cancer enters final testing

NCT ID NCT07216703

Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 17 times

Summary

This phase 3 trial tests whether adding the experimental drug sacituzumab tirumotecan (sac-TMT) to standard immunotherapy (pembrolizumab) and a targeted therapy (bevacizumab) helps people with metastatic cervical cancer live longer. About 1,000 participants whose cancer has spread and who have a specific protein (PD-L1) will receive either the new combo or standard chemo. The study is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sacituzumab tirumotecan (sac-TMT) combined with pembrolizumab (Keytruda) and bevacizumab (Avastin)
What this could lead to
If successful, this combination could become a new first-line maintenance treatment for metastatic cervical cancer, potentially helping patients live longer or delay cancer progression.
What could go wrong
This is a large phase 3 trial, but the combination involves multiple drugs, which may increase side effects. It is not yet proven to be better than current standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 1,023 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Oct 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

The main inclusion criteria include but are not limited to the following: * Has a histologically confirmed diagnosis of squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of cervix * Has persistent, recurrent, or newly diagnosed metastatic (International Federation of Gynecology and Obstetrics \[FIGO\]-2028 Stage IVB) cervical cancer that is not amenable to curative treatment (surgery and/or radiation) * If infected with human immunodeficiency virus (HIV), has well controlled HIV on antiretroviral therapy * If positive for hepatitis B surface antigen, has received hepatitis B virus (HBV) antiviral therapy and has undetectable HBV viral load * If has a history of hepatitis C virus (HCV) infection, has undetectable HCV viral load * Has an Eastern Cooperative Oncology Group performance status of 0 or 1 * Has tumor programmed cell death ligand 1 expression of combined positive score ≥1 The main exclusion criteria include but are not limited to the following: * Has HIV infection with a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease * Has a history of documented severe dry eye syndrome, severe Meibomian gland disease and/or blepharitis, or severe corneal disease that prevents/delays corneal healing * Has active inflammatory bowel disease requiring immunosuppressive medication or previous history of inflammatory bowel disease (eg, Crohn's disease, ulcerative colitis, or chronic diarrhea) * Has uncontrolled, significant cardiovascular disease or cerebrovascular disease * Has received prior systemic anticancer therapy other than what is specified in this protocol * Is currently receiving a strong inducer/inhibitor of cytochrome P450 3A4 that cannot be discontinued for the duration of treatment with sac-TMT * Has a diagnosis of immunodeficiency * Has a known additional malignancy that is progressing or has required active treatment within the past 3 years * Has known active central nervous system metastases and/or carcinomatous meningitis * Has active autoimmune disease that has required systemic treatment in the past 2 years; replacement therapy (eg, thyroxine, insulin, or physiologic corticosteroid) is allowed * Has a history of (noninfectious) pneumonitis/interstitial lung disease (ILD) that required steroids, has current pneumonitis/ILD, or has suspected ILD or pneumonitis that cannot be ruled out by standard diagnostic assessments * Has a history of stem cell/solid organ transplant * Has not adequately recovered from major surgery or has ongoing surgical complications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autosomal dominant Parkinson disease 4 cervical cancer cervical carcinoma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    173 sites in 28 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • ASST Spedali Civili ( Site 2001)

    RECRUITING

    Brescia, 25123, Italy

  • ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 1403)

    RECRUITING

    Chaïdári, Attica, 124 62, Greece

  • AULSS 2 MARCA TREVIGIANA ( Site 2011)

    RECRUITING

    Treviso, 95123, Italy

  • Aichi Cancer Center ( Site 2114)

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 1401)

    RECRUITING

    Athens, Attica, 115 28, Greece

  • Antwerp University Hospital ( Site 0407)

    RECRUITING

    Edegem, Antwerpen, 2650, Belgium

  • Aretaieio Hospital Oncology Unit ( Site 1402)

    RECRUITING

    Athens, Attica, 115 28, Greece

  • Asan Medical Center ( Site 2904)

    RECRUITING

    Seoul, 05505, South Korea

  • Asplundh Cancer Pavilion ( Site 5002)

    RECRUITING

    Willow Grove, Pennsylvania, 19090, United States

  • Azienda Ospedaliera Ordine Mauriziano di Torino ( Site 2006)

    RECRUITING

    Torino, 10128, Italy

  • Bradfordhill ( Site 0702)

    RECRUITING

    Santiago, Region M. de Santiago, 8420383, Chile

  • CANCER TREAMTENT CLINIC AND CLINICAL TRIALS SA DE CV ( Site 2204)

    RECRUITING

    Guadalajara, Jalisco, 44260, Mexico

  • CHRU de Brest-Institut de cancérologie et d'Hématologie ( Site 1202)

    RECRUITING

    Brest, Brittany Region, 29609, France

  • CHU Strasbourg-Hautepierre ( Site 1207)

    RECRUITING

    Strasbourg, Alsace, 67098, France

  • CIDO SpA-Oncology ( Site 0708)

    RECRUITING

    Temuco, Araucania, 4810148, Chile

  • CIUSSS de l Estrie Centre Hospitalier Universitaire de Sherbrooke ( Site 0604)

    RECRUITING

    Sherbrooke, Quebec, J1H 5N4, Canada

  • CRO-IRCCS ( Site 2014)

    RECRUITING

    Aviano, Friuli Venezia Giulia, 33081, Italy

  • Cancer Institute Hospital of JFCR ( Site 2119)

    RECRUITING

    Koto, Tokyo, 135-8550, Japan

  • Carmel Hospital ( Site 1901)

    RECRUITING

    Haifa, 3436212, Israel

  • Centre François Baclesse ( Site 1201)

    RECRUITING

    Caen, Calvados, 14076, France

  • Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 0403)

    RECRUITING

    Liège, Liege, 4000, Belgium

  • Centre Hospitalier de l'Université de Montréal ( Site 0616)

    RECRUITING

    Montreal, Quebec, H2X 0C1, Canada

  • Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0611)

    RECRUITING

    Québec, Quebec, G1J 1Z4, Canada

  • Centro Cancerológico del Caribe (CECAC) ( Site 0906)

    RECRUITING

    Barranquilla, Atlántico, 080002, Colombia

  • Centro Medico Privado CEMAIC ( Site 0102)

    RECRUITING

    Córdoba, X5008AAC, Argentina

  • Centro de Investigacion Clinica de Oaxaca ( Site 2207)

    RECRUITING

    Oaxaca City, 68020, Mexico

  • Centro de Oncología e Investigación de Buenos Aires ( Site 0107)

    RECRUITING

    Berazategui, Buenos Aires, B1884BBF, Argentina

  • Chang Gung Memorial Hospital ( Site 3302)

    RECRUITING

    Taoyuan, 333, Taiwan

  • Chulalongkorn University ( Site 3403)

    RECRUITING

    Bangkok, Bangkok, 10330, Thailand

  • Clinica Somer ( Site 0903)

    RECRUITING

    Rionegro, Antioquia, 054040, Colombia

  • Cliniques Universitaires Saint-Luc ( Site 0402)

    RECRUITING

    Brussels, Bruxelles-Capitale, Region de, 1200, Belgium

  • Cork University Hospital ( Site 1802)

    RECRUITING

    Cork, T12 E8YV, Ireland

  • Curo Oncology. ( Site 2811)

    RECRUITING

    Pretoria, Gauteng, 0084, South Africa

  • Debreceni Egyetem Klinikai Kozpont ( Site 1601)

    RECRUITING

    Debrecen, 4032, Hungary

  • Ehime University Hospital ( Site 2105)

    RECRUITING

    Tōon, Ehime, 791-0295, Japan

  • FALP ( Site 0701)

    RECRUITING

    Santiago, Region M. de Santiago, 7500921, Chile

  • Faculty of Medicine Siriraj Hospital ( Site 3401)

    RECRUITING

    Bangkok, Bangkok, 10700, Thailand

  • Fakultni nemocnice Kralovske Vinohrady ( Site 1002)

    RECRUITING

    Prague, Praha 10, 100 34, Czechia

  • Fakultni nemocnice Ostrava ( Site 1005)

    RECRUITING

    Ostrava, Moravian-Silesian Region, 708 52, Czechia

  • Fakultní Nemocnice Brno ( Site 1003)

    RECRUITING

    Brno, Brno-mesto, 602 00, Czechia

  • Florida Cancer Specialists - East ( Site 7000)

    RECRUITING

    West Palm Beach, Florida, 33401, United States

  • Florida Cancer Specialists - South ( Site 7001)

    RECRUITING

    Fort Myers, Florida, 33901, United States

  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 2008)

    RECRUITING

    Milan, Milano, 20133, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Ginecologia Oncologica ( Site 2012)

    RECRUITING

    Roma, 00168, Italy

  • Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto ( Site 0512)

    RECRUITING

    São José do Rio Preto, São Paulo, 15091-000, Brazil

  • Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0111)

    RECRUITING

    La Rioja, F5300COE, Argentina

  • Fundación Respirar ( Site 0101)

    RECRUITING

    Belgrano, Buenos Aires F.D., C1118AAT, Argentina

  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0511)

    RECRUITING

    Barretos, São Paulo, 14784-400, Brazil

  • Grand Hopital de Charleroi ( Site 0404)

    RECRUITING

    Charleroi, Hainaut, 6060, Belgium

  • Grupo Médico ASSET SC ( Site 2203)

    RECRUITING

    Benito Juárez, Mexico City, 03100, Mexico

  • Gunma Prefectural Cancer Center ( Site 2109)

    RECRUITING

    Ōta, Gunma, 373-8550, Japan

  • Higiea Oncologia ( Site 2205)

    RECRUITING

    Mexico City, Mexico City, 11819, Mexico

  • Hillel Yaffe Medical Center ( Site 1903)

    RECRUITING

    Hadera, 0038100, Israel

  • Honickman Center ( Site 5033)

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • Hopelands Cancer Centre ( Site 2816)

    RECRUITING

    Hilton, KwaZulu-Natal, 3245, South Africa

  • Hopital Europeen Georges Pompidou ( Site 1210)

    RECRUITING

    Paris, 75015, France

  • Hosp Clinico Universitario de Valencia ( Site 3001)

    RECRUITING

    Valencia, Valenciana, Comunitat, 46010, Spain

  • Hospital Araújo Jorge ( Site 0518)

    RECRUITING

    Goiânia, Goiás, 74605070, Brazil

  • Hospital Provincial del Centenario ( Site 0106)

    RECRUITING

    Rosario, Santa Fe Province, S2002KDS, Argentina

  • Hospital Ramon y Cajal ( Site 3005)

    RECRUITING

    Madrid, 28034, Spain

  • Hospital São Lucas da PUCRS ( Site 0516)

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90610-000, Brazil

  • Hospital Universitari Vall d Hebron ( Site 3003)

    RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitario 12 de Octubre ( Site 3007)

    RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario La Paz ( Site 3004)

    RECRUITING

    Madrid, 28046, Spain

  • Hospital Universitario Reina Sofia ( Site 3006)

    RECRUITING

    Córdoba, 14004, Spain

  • Houston Methodist Hospital-Obstetrics and Gynecology ( Site 6010)

    RECRUITING

    Houston, Texas, 77030, United States

  • Hyogo Cancer Center ( Site 2118)

    RECRUITING

    Akashi, Hyōgo, 673-8558, Japan

  • IBCC - Instituto Brasileiro de Controle do Câncer ( Site 0517)

    RECRUITING

    São Paulo, São Paulo, 04014-002, Brazil

  • IC La Serena Research ( Site 0710)

    RECRUITING

    La Serena, Coquimbo Region, 1720430, Chile

  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 2009)

    RECRUITING

    Meldola, Forli-Cesena, 47014, Italy

  • Inova Schar Cancer Institute ( Site 5045)

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 1204)

    RECRUITING

    Bordeaux, Gironde, 33076, France

  • Institut Català d'Oncologia (ICO) - Girona ( Site 3002)

    RECRUITING

    Girona, Gerona, 17007, Spain

  • Instituto Misionero del Cancer ( Site 0112)

    RECRUITING

    Posadas, Misiones Province, N3300KAZ, Argentina

  • Instituto Nacional De Cancerologia ( Site 0909)

    RECRUITING

    Bogotá, Bogota D.C., 111511, Colombia

  • Instituto Nacional de Câncer - INCA ( Site 0515)

    RECRUITING

    Rio de Janeiro, 20220-410, Brazil

  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 0105)

    RECRUITING

    Mar del Plata, Buenos Aires, B7600FZO, Argentina

  • Instituto de Oncologia de Rosario ( Site 0104)

    RECRUITING

    Rosario, Santa Fe Province, S2000KZE, Argentina

  • Irmandade da Santa Casa de Misericordia de Porto Alegre ( Site 0514)

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90020-090, Brazil

  • Istituto Europeo di Oncologia ( Site 2003)

    RECRUITING

    Milan, 20141, Italy

  • Istituto Oncologico Veneto IRCCS ( Site 2005)

    RECRUITING

    Padova, 35128, Italy

  • Iwate Medical University Hospital ( Site 2116)

    RECRUITING

    Shiwa-gun, Iwate, 028-3695, Japan

  • KLES Prabhakar Kore Hospital & Medical Research Centre [M] ( Site 1705)

    RECRUITING

    Belagavi, Karnataka, 590010, India

  • Kanagawa Cancer Center ( Site 2121)

    RECRUITING

    Yokohama, Kanagawa, 241-8515, Japan

  • Karolinska Universitetssjukhuset-Solna ( Site 3102)

    RECRUITING

    Stockholm, Stockholm County, 171 64, Sweden

  • Keio University Hospital ( Site 2103)

    RECRUITING

    Shinjyuku, Tokyo, 160-8582, Japan

  • Kurume University Hospital ( Site 2112)

    RECRUITING

    Kurume, Fukuoka, 830-0011, Japan

  • LBM ONCOPOLE CLAUDIUS REGAUD ( Site 1203)

    RECRUITING

    Toulouse, Haute-Garonne, 31059, France

  • Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 2202)

    RECRUITING

    Monterrey, Nuevo León, 64460, Mexico

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6009)

    RECRUITING

    New York, New York, 10016, United States

  • Liga Norte Riograndense Contra o Câncer ( Site 0513)

    RECRUITING

    Natal, Rio Grande do Norte, 59062-000, Brazil

  • Linköping University Hospital ( Site 3101)

    RECRUITING

    Linköping, Östergötland County, 581 85, Sweden

  • London Health Sciences Centre ( Site 0613)

    RECRUITING

    London, Ontario, N6A 5W9, Canada

  • Mackay Memorial Hospital ( Site 3303)

    RECRUITING

    Taipei, 10449, Taiwan

  • Maharaj Nakorn Chiang Mai Hospital ( Site 3402)

    RECRUITING

    Chiang Mai, 50200, Thailand

  • Mahatma Gandhi Cancer Hospital and Research Institute ( Site 1714)

    RECRUITING

    Visakhapatnam, Andhra Pradesh, 530017, India

  • Makati Medical Center ( Site 2503)

    RECRUITING

    Makati City, National Capital Region, 1229, Philippines

  • Manila Doctors Hospital ( Site 2501)

    RECRUITING

    Manila, National Capital Region, 1000, Philippines

  • Maryland Oncology Hematology (MOH) ( Site 8001)

    RECRUITING

    Columbia, Maryland, 21044, United States

  • Mater Misercordiae University Hospital ( Site 1804)

    ACTIVE_NOT_RECRUITING

    Dublin, D07 R2WY, Ireland

  • Mazowiecki Szpital Wojewódzki w Siedlcach ( Site 2601)

    RECRUITING

    Siedlce, Warmian-Masurian Voivodeship, 08-110, Poland

  • McGill University Health Centre ( Site 0602)

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Medizinische Universitaet Innsbruck ( Site 0301)

    RECRUITING

    Innsbruck, Tyrol, 6020, Austria

  • Medizinische Universitaet Wien ( Site 0302)

    RECRUITING

    Vienna, State of Vienna, 1090, Austria

  • Medizinische Universitat Graz ( Site 0303)

    RECRUITING

    Graz, Styria, 8036, Austria

  • Minnesota Oncology Hematology, PA ( Site 8003)

    RECRUITING

    Edina, Minnesota, 55435, United States

  • Mount Sinai Braman Comprehensive Cancer Center ( Site 5043)

    RECRUITING

    Miami Beach, Florida, 33140, United States

  • Mount Sinai Comprehensive Cancer Center ( Site 6000)

    RECRUITING

    Miami Beach, Florida, 33140, United States

  • Nancy N. & J.C. Lewis Cancer and Research Pavillion - Research Department ( Site 6005)

    RECRUITING

    Savannah, Georgia, 31405, United States

  • Narodowy Instytut Onkologii - Oddzial w Gliwicach-III Klinika Radioterapii i Chemioterapii ( Site 2604)

    RECRUITING

    Gliwice, Silesian Voivodeship, 44-102, Poland

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 2605)

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • National Cancer Center ( Site 2905)

    RECRUITING

    Goyang-si, Kyonggi-do, 10408, South Korea

  • National Cheng Kung University Hospital ( Site 3308)

    RECRUITING

    Tainan, 704, Taiwan

  • National Hospital Organization Hokkaido Cancer Center ( Site 2108)

    RECRUITING

    Sapporo, Hokkaido, 003-0804, Japan

  • National Hospital Organization Kyushu Cancer Center ( Site 2102)

    RECRUITING

    Fukuoka, 811-1395, Japan

  • National Taiwan University Hospital ( Site 3301)

    RECRUITING

    Taiwan, Taipei, 10002, Taiwan

  • Nemocnice AGEL Novy Jicin a.s. ( Site 1004)

    RECRUITING

    Nový Jičín, Moravian-Silesian Region, 741 01, Czechia

  • Niigata Cancer Center Hospital ( Site 2110)

    RECRUITING

    Niigata, 951-8566, Japan

  • Nova Scotia Cancer Centre ( Site 0617)

    RECRUITING

    Halifax, Nova Scotia, B3H 1V7, Canada

  • ONCOCENTRO APYS-ACEREY ( Site 0703)

    RECRUITING

    Viña del Mar, Valparaiso, 2520598, Chile

  • Okayama University Hospital ( Site 2101)

    RECRUITING

    Okayama, 700-8558, Japan

  • Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001)

    RECRUITING

    Tulsa, Oklahoma, 74146, United States

  • Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8007)

    RECRUITING

    Eugene, Oregon, 97401, United States

  • Oncomédica S.A.S ( Site 0905)

    RECRUITING

    Montería, Departamento de Córdoba, 230002, Colombia

  • Oncólogos del Occidente S.A.S. ( Site 0908)

    RECRUITING

    Pereira, Risaralda Department, 660001, Colombia

  • Országos Onkológiai Intézet ( Site 1603)

    RECRUITING

    Budapest, 1122, Hungary

  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 2111)

    RECRUITING

    Osaka, 541-8567, Japan

  • Ospedale Cannizzaro ( Site 2010)

    RECRUITING

    Catania, 95126, Italy

  • Ospedale Humanitas San Pio X ( Site 2013)

    RECRUITING

    Milan, Lombardy, 20159, Italy

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5039)

    RECRUITING

    Mineola, New York, 11501, United States

  • Perpetual Succour Hospital ( Site 2502)

    RECRUITING

    Cebu City, Cebu, 6000, Philippines

  • Pontificia Universidad Catolica de Chile-CICUC ( Site 0706)

    RECRUITING

    Santiago, Region M. de Santiago, 8330073, Chile

  • Princess Margaret Cancer Centre ( Site 0601)

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Pôle Santé Léonard de Vinci ( Site 1209)

    RECRUITING

    Chambray-lès-Tours, Centre-Val de Loire, 37170, France

  • Rabin Medical Center ( Site 1904)

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Ramathibodi Hospital ( Site 3404)

    RECRUITING

    Bangkok, Bangkok, 10400, Thailand

  • Rambam Health Care Campus ( Site 1907)

    RECRUITING

    Haifa, 3109601, Israel

  • Saitama Medical University International Medical Center ( Site 2106)

    RECRUITING

    Hidaka, Saitama, 350-1298, Japan

  • Samsung Medical Center ( Site 2903)

    RECRUITING

    Seoul, 06351, South Korea

  • Scientia Investigacion Clinica S.C. ( Site 2201)

    RECRUITING

    Chihuahua City, 31207, Mexico

  • Seoul National University Hospital ( Site 2901)

    RECRUITING

    Jongno-gu, Seoul, 03080, South Korea

  • Severance Hospital Yonsei University Health System ( Site 2902)

    RECRUITING

    Seodaemun-Gu, Seoul, 03722, South Korea

  • Shaare Zedek Medical Center ( Site 1905)

    RECRUITING

    Jerusalem, 9103102, Israel

  • Shizuoka Cancer Center ( Site 2104)

    RECRUITING

    Sunto-gun,, Shizuoka, 411-8777, Japan

  • Skanes Universitetssjukhus Lund ( Site 3103)

    RECRUITING

    Lund, Skåne County, 22242, Sweden

  • Sourasky Medical Center ( Site 1902)

    RECRUITING

    Tel Aviv, 6423906, Israel

  • St Jame's Hospital ( Site 1801)

    RECRUITING

    Dublin, D08 NHY1, Ireland

  • Sunnybrook Research Institute ( Site 0605)

    RECRUITING

    Toronto, Ontario, M4N 3M5, Canada

  • Swietokrzyskie Centrum Onkologii. ( Site 2602)

    RECRUITING

    Kielce, Świętokrzyskie Voivodeship, 25-734, Poland

  • TRIALS 365 ( Site 6008)

    RECRUITING

    Shreveport, Louisiana, 71103, United States

  • Taichung Veterans General Hospital ( Site 3304)

    RECRUITING

    Taichung, 40705, Taiwan

  • Texas Oncology - DFW ( Site 8005)

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • Texas Oncology - Northeast Texas ( Site 8002)

    RECRUITING

    Tyler, Texas, 75702, United States

  • Texas Oncology-The Woodlands ( Site 8000)

    RECRUITING

    The Woodlands, Texas, 77380, United States

  • The Christie Hospital NHS Foundation Trust ( Site 3602)

    RECRUITING

    Withington, Manchester, M20 4BX, United Kingdom

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6002)

    RECRUITING

    Columbus, Ohio, 43210, United States

  • The Jikei University Hospital ( Site 2107)

    RECRUITING

    Minato, Tokyo, 105-8471, Japan

  • UZ Gent ( Site 0406)

    RECRUITING

    Ghent, Oost-Vlaanderen, 9000, Belgium

  • UZ Leuven ( Site 0401)

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

  • Uniklinikum Salzburg Landeskrankenhaus ( Site 0304)

    RECRUITING

    Salzburg, 5020, Austria

  • Univ. Pretoria and Steve Biko Academic Hospitals ( Site 2804)

    RECRUITING

    Pretoria, Gauteng, 0002, South Africa

  • Universitaetsklinikum Jena ( Site 1303)

    RECRUITING

    Jena, Thuringia, 07747, Germany

  • University of Alabama- Birmingham ( Site 5015)

    RECRUITING

    Birmingham, Alabama, 35294, United States

  • University of Tennessee Medical Center ( Site 6012)

    RECRUITING

    Knoxville, Tennessee, 37920, United States

  • University of Virginia Cancer Center ( Site 5044)

    RECRUITING

    Charlottesville, Virginia, 22908, United States

  • University of Virginia Cancer Center ( Site 6014)

    RECRUITING

    Charlottesville, Virginia, 22908, United States

  • University of the Ryukyus Hospital ( Site 2117)

    RECRUITING

    Ginowan, Okinawa, 901-2725, Japan

  • Vseobecna fakultni nemocnice v Praze-Gynekologicko-porodnicka klinika 1.LF a VFN ( Site 1001)

    RECRUITING

    Prague, 128 08, Czechia

  • Western General Hospital ( Site 3604)

    RECRUITING

    Edinburgh, Edinburgh, City of, EH4 2XU, United Kingdom

  • Winship Cancer Institute of Emory University ( Site 5005)

    RECRUITING

    Atlanta, Georgia, 30308, United States

  • Wits Clinical Research ( Site 2803)

    RECRUITING

    Johannesburg, Gauteng, 2193, South Africa

  • Wits Clinical Research ( Site 2813)

    RECRUITING

    Soweto, Gauteng, 2113, South Africa

  • Women & Infants Hospital ( Site 6003)

    RECRUITING

    Providence, Rhode Island, 02905, United States

  • Women's Cancer Center of Nevada ( Site 6011)

    RECRUITING

    Las Vegas, Nevada, 89106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.